Epoprostenol Sodium

CAS 61849-14-7 6 FDA-DMF suppliersSmall Molecule

Overview

Epoprostenol Sodium is a potent vasodilator and inhibitor of platelet aggregation, used predominantly in the treatment of pulmonary arterial hypertension. It mimics the effects of endogenous prostacyclin, improving blood flow and reducing blood pressure in the lungs.

API suppliers (5)

Suppliers of Epoprostenol Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • CAYMAN PHARMA SRO1 active DMF
  • CAYMAN PHARMA SRO1 active DMF
  • CAYMAN PHARMA SRO1 active DMF
  • EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan
  • JOHNSON MATTHEY PHARMA SERVICES

Therapeutic areas

CardiovascularPulmonologyRheumatology

Related APIs

Rivaroxaban
57 suppliers
Apixaban
51 suppliers
Telmisartan
43 suppliers
Empagliflozin
42 suppliers
Clopidogrel
40 suppliers
Olmesartan Medoxomil
38 suppliers
Valsartan
37 suppliers
Amlodipine
34 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo